miR-181a targets GATA6 to inhibit the progression of human laryngeal squamous cell carcinoma

miR-181 elevates Akt signaling by co-targeting PHLPP2 and INPP4B phosphatases in luminal breast cancer

(2017) Michaela Strotbek et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNAs and tRNA-derived fragments predict the transformation of myelodysplastic syndromes to acute myeloid leukemia

(2017) Yan Guo et al.   LEUKEMIA & LYMPHOMA

MiR-181b modulates EGFR-dependent VCAM-1 expression and monocyte adhesion in glioblastoma

(2017) Y-S Liu et al.   ONCOGENE

Anisomycin-induced GATA-6 degradation accompanying a decrease of proliferation of colorectal cancer cell

(2016) Hironori Ushijima et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer

(2016) Fei Tian et al.   GENE

GATA6 regulates EMT and tumour dissemination, and is a marker of response to adjuvant chemotherapy in pancreatic cancer

(2016) Paola Martinelli et al.   GUT

The miR-196b miRNA inhibits the GATA6 intestinal transcription factor and is upregulated in colon cancer patients

(2016) Sebastian Fantini et al.   Oncotarget

GATA6 is overexpressed in breast cancer and promotes breast cancer cell epithelial–mesenchymal transition by upregulating slug expression

(2015) Yongchun Song et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Long non-coding RNA MEG3 functions as a competing endogenous RNA to regulate gastric cancer progression

(2015) Weizhao Peng et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Extensive sequence variation in the 3′ untranslated region of theKRASgene in lung and ovarian cancer cases

(2014) Minlee Kim et al.   CELL CYCLE

miR-21, miR-106b and miR-375 as Novel Potential Biomarkers for Laryngeal Squamous Cell Carcinoma

(2014) Xing Yu et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Long-term trends in gender, T-stage, subsite and treatment for laryngeal cancer at a single center

(2014) Jesper Brandstorp-Boesen et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

MicroRNA-181 functions as a tumor suppressor in non-small cell lung cancer (NSCLC) by targeting Bcl-2

(2014) Ping Huang et al.   TUMOR BIOLOGY

Clinical update on cancer: molecular oncology of head and neck cancer

(2014) Y Suh et al.   Cell Death & Disease

microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression

(2014) SHI-JUN TONG et al.   Experimental and Therapeutic Medicine

miR-181a is associated with poor clinical outcome in patients with colorectal cancer treated with EGFR inhibitor

(2013) Martin Pichler et al.   JOURNAL OF CLINICAL PATHOLOGY

miR-181 as a putative biomarker for lymph-node metastasis of oral squamous cell carcinoma

(2011) Cheng-Chieh Yang et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Overexpression of SATB1 in Laryngeal Squamous Cell Carcinoma

(2010) Xu-Dong Zhao et al.   ORL-Journal for Oto-Rhino-Laryngology Head and Neck Surgery

TGFβ-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3

(2009) B Wang et al.   ONCOGENE